|
Jul 31
|
What Trump's Big Pharma CEO letters mean for drug pricing power
|
|
Jul 31
|
Biomarkers may address unmet needs of idiopathic pulmonary fibrosis treatment
|
|
Jul 31
|
AbbVie Beats on Q2 Earnings & Sales, Stock Up on Raised '25 EPS View
|
|
Jul 31
|
Biogen's Q2 Earnings & Sales Beat, 2025 Outlook Raised, Stock Up
|
|
Jul 31
|
Renal Failure Clinical Trials Market Landscape Report 2025 Featuring Bayer, AstraZeneca, Amgen, Sanofi, Novartis, AbbVie, Roche, Pfizer, Takeda, Astellas
|
|
Jul 31
|
Multiple Sclerosis Clinical Trials Market Landscape Report 2025 Featuring Biogen, Novartis, Sanofi, Merck, Teva, Bayer, Roche, Bristol-Myers Squibb, Laboratory Corp of America, IQVIA
|
|
Jul 31
|
Roche Holding's (VTX:ROG) Conservative Accounting Might Explain Soft Earnings
|
|
Jul 30
|
Roche pushes ahead with late-comer strategy in obesity
|
|
Jul 29
|
AAIC25: ALZpath’s pTau217 advances role in Alzheimer’s disease R&D
|
|
Jul 29
|
Why value investing has worked better outside the US
|
|
Jul 29
|
Rapid Expansion and Innovation Drive $36 Billion Global Point-of-Care Diagnostics Market, Says New Kalorama Report
|
|
Jul 29
|
EXEL Q2 Earnings Top, Sales Miss on Lower Collaboration Revenues
|
|
Jul 29
|
Sarepta shares rebound after shipments of gene therapy Elevidys resume in US
|
|
Jul 29
|
North America Autoimmune Disease Diagnostics Market Report 2025-2033 Featuring Bio-Rad, Abbott, Roche, Quest Diagnostics, Thermo Fisher Scientific, BioMerieux, Myriad Genetics, Siemens Healthineers
|
|
Jul 28
|
EU-US trade deal could add up to $19 billion in pharma industry costs, analysts say
|
|
Jul 28
|
Tweedy Browne International Value Reduces Stake in Zurich Insurance Group AG by 74.44%
|
|
Jul 28
|
Pre-Q2 Earnings: Is AbbVie Stock a Portfolio Must-Have?
|
|
Jul 28
|
Will These 5 Pharma/Biotech Bigwigs Surpass Q2 Earnings Forecasts?
|
|
Jul 28
|
Sarepta Stock Rises Despite Downgrade and FDA Probe. The Crisis Explained.
|
|
Jul 28
|
FDA Probes Death Of 8-Year-Old Who Received Sarepta's Elevidys
|